To investigate the cistrome of NR2F2 and its presence in the ERα-mediated transcriptional complex, we performed chromatin immunoprecipitation followed by sequencing (ChIP-seq) with NR2F2 and ERα antibodies using two luminal A breast cancer cells (MCF-7 and T47D). The gene discussed is NR2F2; the disease is breast cancer.